Bio-Tissue specializes in regenerative medicine, focusing on the use of birth tissue products, particularly amniotic membrane, to promote healing. Their proprietary CryoTek® technology is a key innovation that preserves the biological and structural integrity of amniotic tissue, allowing it to maintain its natural healing properties. This technology has been shown to facilitate regenerative healing by modulating inflammation and minimizing scar tissue formation, which is crucial for effective recovery. Bio-Tissue's products, such as Prokera®, are designed for ocular applications, providing a therapeutic solution for various eye conditions by creating an optimal environment for the cornea to heal.

The company emphasizes the importance of ethical practices in tissue donation, sourcing amniotic membrane from healthy mothers after cesarean births, and adhering to stringent regulatory standards. With over 680,000 allografts transplanted, Bio-Tissue has established a significant presence in the field of regenerative medicine, backed by extensive research and clinical applications. Their commitment to advancing the science of regenerative healing is evident in their ongoing development of innovative products aimed at improving patient outcomes across a range of medical conditions.

United States

BioTissue is the leader in innovative applications of human birth tissues for regenerative wound healing, aiming to improve patient outcomes. The company is committed to promoting regenerative healing through its birth tissue products.

Bio-Tissue

Company Details